Delivery Order SPE2DE24D0013-SPE2D626F251X
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $27,650.40 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025. This firm fixed-price delivery order, designated XPRSMVP-10 with completion targeted for November 20, 2025, represents a procurement of diagnostic testing supplies and reagents under an existing indefinite delivery contract vehicle. The award carries no set-aside designation,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,720 on October 29, 2025, by the Defense Logistics Agency Medical Supply Chain for diagnostic testing supplies and reagents. The delivery order, designated as XPRS4PLEX-10, is structured as a firm fixed-price contract with an ultimate completion date of November 5, 2025, and no set-aside designation. This award falls under Cepheid's broader contracting...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,992 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems and reagents, on November 5, 2025, with an ultimate completion date of November 20, 2025. This firm fixed-price delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic supplies related to COVID-19, influenza, and respiratory syncytial virus testing. The contract carries no set-aside designation,...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $17,162.40 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025. This delivery order, designated XPRSMVP-10, is set to be completed by October 27, 2025, and represents an order for molecular diagnostic reagents and test kits designed for the GeneXpert diagnostic platform. The work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,040 on November 17, 2025, to Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems. This firm fixed-price delivery order, designated XPRS4PLEX-10 with completion slated for November 24, 2025, is issued under an existing Indefinite Delivery Contract framework. The award carries no set-aside designation, reflecting Cepheid's competitive positioning as an established...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $2,595.60 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a task order under one of Cepheid's existing indefinite delivery vehicle contracts that enables the federal government to procure molecular diagnostic...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $1,800 firm fixed-price delivery order to Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California. This delivery order, issued on August 25, 2025, with an ultimate completion date of September 2, 2025, carries no set-aside designation and represents a continuation of the agency's procurement of advanced diagnostic solutions. The work will be performed at Cepheid's Sunnyvale facility....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $7,373.44 to Cepheid Inc. on November 13, 2025, for delivery to the company's headquarters in Sunnyvale, California. This firm fixed-price delivery order, designated XPRSMVP-10, is structured as a non-competitive award with an ultimate completion date of November 20, 2025. The contract represents a continuation of Cepheid's established role as a primary federal supplier of molecular diagnostic solutions,...
- The U.S. Defense Logistics Agency (Medical Supply Chain) awarded a firm fixed-price delivery order valued at $3,708.00 to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California. The delivery order, issued on September 5, 2025, with an ultimate completion date of September 12, 2025, carries no set-aside designation. This award represents a discrete delivery order under one of Cepheid's larger indefinite delivery vehicle contracts with the...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, was awarded a delivery order valued at $5,236.00 by the Defense Logistics Agency Medical Supply Chain on October 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing supplies supporting detection of COVID-19, influenza, and respiratory syncytial virus, with a firm fixed-price structure and ultimate completion date of November 10, 2025. The contract...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F251XDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,760 on November 18, 2025, to Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents. The award, designated as XPRSTREPA-10, is a firm fixed-price delivery order with an ultimate completion date of November 25, 2025, and carries no set-aside designation. As a specialized supplier of rapid molecular diagnostic testing solutions, Cepheid will perform work at its Sunnyvale, CA facility. The company has established itself as a primary federal supplier of diagnostic solutions through its GeneXpert diagnostic platform and associated molecular testing capabilities for infectious diseases including COVID-19, influenza, respiratory syncytial virus, tuberculosis, and other conditions. This delivery order represents a continuation of Cepheid's extensive federal contracting relationships across multiple healthcare agencies. The company maintains significant Indefinite Delivery Contracts with the Department of Veterans Affairs, including a $32.8 million contract with VISN 6 extending through September 2030 and a $6.7 million contract with VISN 17 through December 2029, which serve as the foundational vehicles for ongoing procurement of diagnostic reagents, test kits, and related services. Cepheid's federal portfolio demonstrates substantial capability in supplying molecular diagnostic equipment and testing solutions to the Defense Health Agency, Indian Health Service, U.S. Coast Guard, and Department of Veterans Affairs across distributed healthcare networks, with all contracts utilizing firm fixed-price structures consistent with this delivery order award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 11/18/25 |